Skip to main content

Verrica Pharmaceuticals Inc.

VRCA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001660334

In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Verrica Pharmaceuticals Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of VRCA: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders6367+4
Shares14.6M15.1M+449.8K (+3.1%)
Value$84.2M$58.5M−$25.8M (−30.6%)

New holders (12)

Institutions that held Verrica Pharmaceuticals Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to VRCA in Q3 2023
InstitutionSharesValue% of portfolio
Caligan Partners LP259,593$1.01M0.52%
Boxer Capital, LLC166,955$648.6K0.03%
AQR Capital Management LLC21,968$85.3K0.00%
Stifel Financial Corp20,500$79.6K0.00%
Jump Financial, LLC18,200$70.7K0.00%
Squarepoint Ops LLC16,874$65.6K0.00%
American Century Companies Inc15,276$59.3K0.00%
Group One Trading, L.P.13,778$53.5K0.00%
Allspring Global Investments Holdings, LLC6,279$24.4K0.00%
Salomon & Ludwin, LLC2,900$11.3K0.00%
Deutsche Bank AG114$4430.00%
Advisor Group Holdings, Inc.100$3890.00%

Sold out (8)

Institutions that held Verrica Pharmaceuticals Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of VRCA in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Marshall Wace, LLP53,930$311.2K
Two Sigma Advisers, LP26,300$151.8K
Verition Fund Management LLC14,930$86.1K
Vontobel Holding Ltd.13,570$78.3K
MetLife Investment Management11,190$64.6K
Newbridge Financial Services Group, Inc.3,000$17.3K
Metropolitan Life Insurance Co1,160$6.69K
Benjamin F. Edwards & Company, Inc.500$3.00K